Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Trevena Inc (TRVN)

Trevena Inc (TRVN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 24,038
  • Shares Outstanding, K 6,947
  • Annual Sales, $ 570 K
  • Annual Income, $ -51,590 K
  • 60-Month Beta 1.86
  • Price/Sales 42.52
  • Price/Cash Flow N/A
  • Price/Book 1.10
Trade TRVN with:

Options Overview Details

View History
  • Implied Volatility 212.83% ( -0.71%)
  • Historical Volatility 142.39%
  • IV Percentile 69%
  • IV Rank 17.59%
  • IV High 1,158.58% on 07/25/22
  • IV Low 10.97% on 01/18/22
  • Put/Call Vol Ratio 10.91
  • Today's Volume 131
  • Volume Avg (30-Day) 139
  • Put/Call OI Ratio 0.10
  • Today's Open Interest 35,401
  • Open Int (30-Day) 34,800

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -1.73
  • Number of Estimates 1
  • High Estimate -1.73
  • Low Estimate -1.73
  • Prior Year -2.00
  • Growth Rate Est. (year over year) +13.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.38 +45.17%
on 11/11/22
4.70 -26.49%
on 11/07/22
-0.80 (-18.80%)
since 10/28/22
3-Month
2.38 +45.17%
on 11/11/22
5.65 -38.82%
on 08/31/22
-1.80 (-34.25%)
since 08/30/22
52-Week
2.38 +45.17%
on 11/11/22
19.00 -81.81%
on 12/08/21
-14.15 (-80.38%)
since 11/26/21

Most Recent Stories

More News
Trevena (TRVN) Reports Q3 Loss, Misses Revenue Estimates

Trevena (TRVN) delivered earnings and revenue surprises of 0% and 203.06%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

TRVN : 3.45 (-0.14%)
SPRO : 1.9400 (+0.52%)
Trevena: Q3 Earnings Snapshot

Trevena: Q3 Earnings Snapshot

TRVN : 3.45 (-0.14%)
Bluebird Bio (BLUE) Reports Q3 Loss, Misses Revenue Estimates

Bluebird (BLUE) delivered earnings and revenue surprises of 28.13% and 96.84%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

BLUE : 7.79 (+1.83%)
TRVN : 3.45 (-0.14%)
What Makes Trevena (TRVN) a New Buy Stock

Trevena (TRVN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

TRVN : 3.45 (-0.14%)
Trevena (TRVN) Reports Q2 Loss, Lags Revenue Estimates

Trevena (TRVN) delivered earnings and revenue surprises of 18.18% and 100%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

TRVN : 3.45 (-0.14%)
VRDN : 25.27 (+10.45%)
Trevena Reports Second Quarter 2022 Results and Provides Business Update

OLINVYK post-approval strategy advances with positive topline cognitive function data and continued enrollment in VOLITION clinical outcomes study Phase 1...

TRVN : 3.45 (-0.14%)
Halozyme Therapeutics (HALO) Q2 Earnings and Revenues Beat Estimates

Halozyme Therapeutics (HALO) delivered earnings and revenue surprises of 6% and 15.41%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

HALO : 57.26 (+0.37%)
TRVN : 3.45 (-0.14%)
Eiger BioPharmaceuticals (EIGR) Reports Q2 Loss, Tops Revenue Estimates

Eiger BioPharma (EIGR) delivered earnings and revenue surprises of 28.17% and 94.81%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

EIGR : 4.54 (+4.85%)
TRVN : 3.45 (-0.14%)
Trevena, Inc. Announces Closing of Registered Direct Offering of Preferred Stock

CHESTERBROOK, Pa., July 29, 2022 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN) ("Trevena" or the "Company"), a biopharmaceutical company focused on...

TRVN : 3.45 (-0.14%)
Trevena Announces Positive Topline OLINVYK Cognitive Function Data and Provides General Business Update

OLINVYK demonstrated statistically significant reduced impact on neurocognitive functioning vs IV morphine on primary endpoint Successfully negotiated...

TRVN : 3.45 (-0.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Trevena, Inc. is a biopharmaceutical company. It focuses on discovering and developing therapeutics for G protein coupled receptors. The Company's product pipeline includes TRV027, TRV130, TRV734 and Delta opioid biased ligand which are in different clinical phases. Trevena, Inc. is based in King of...

See More

Key Turning Points

3rd Resistance Point 4.15
2nd Resistance Point 3.82
1st Resistance Point 3.64
Last Price 3.45
1st Support Level 3.13
2nd Support Level 2.80
3rd Support Level 2.62

See More

52-Week High 19.00
Fibonacci 61.8% 12.65
Fibonacci 50% 10.69
Fibonacci 38.2% 8.73
Last Price 3.45
52-Week Low 2.38

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar